Pregled bibliografske jedinice broj: 172259
Initial clinical experience with brinzolamid 1% ophthalmic suspension (Azopt)
Initial clinical experience with brinzolamid 1% ophthalmic suspension (Azopt) // Acta Clinica Croatica, 42 (2003), 101-104 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 172259 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Initial clinical experience with brinzolamid 1% ophthalmic suspension (Azopt)
Autori
Novak-Lauš, Katia ; Iveković, Renata ; Bojić, Lovro ; Koršić, Jadranka ; Zorić-Geber, Mia
Izvornik
Acta Clinica Croatica (0353-9466) 42
(2003);
101-104
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
carbonic anhydrase inhibitors; glaucoma drug therapy
Sažetak
The aim of this study was to assess the intraocular hypotensive effect of 1% brinzolamide as monotherapy in patients with primary and secondary glaucoma.The six months study included 20 patients of which 19 completed the study.All patients had prevously received local antiglaucoma therapy.Resulst of this study suggested monotherapy with 1.0% brinzolamid to be successful in the regulation of intraocular pressure in patients with primary or secundary glaucoma
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
0134007
Ustanove:
KBC "Sestre Milosrdnice"
Profili:
Lovro Bojić
(autor)
Katia Novak-Lauš
(autor)
Mia Zorić Geber
(autor)
Renata Iveković
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus